The New York attorney general issued subpoenas to the big three insulin makers — Sanofi, Eli Lilly and Novo Nordisk — seeking documents related to their pricing strategies, according to STAT.

Capping the prices that pharmaceutical companies are allowed to charge for drugs won't lower healthcare costs in the U.S., Eli Lilly CEO David Ricks told CNBC. 

If the merger of Pfizer's off-patent drug unit and Mylan is approved, Mylan CEO Heather Bresch could earn more than $37.6 million in severance and vested benefits, according to The Pittsburgh Post Gazette. 

The Trump administration unveiled a plan July 31 that would allow the U.S. to import drugs from Canada, according to The Hill. 

Teva Pharmaceuticals and Endo International will pay nearly $70 million to California to settle a lawsuit accusing them of striking agreements to delay generic drugs from entering the market, according to The Los Angeles Times. A third drugmaker, Teikoku Pharma,…

Surescripts is threatening to end its contract with a vendor it claims fraudulently requested patient medication history to give to Amazon's online pharmacy PillPack and will turn the matter over to the FBI, according to CNBC. It is the latest…

Below are six legal actions involving members of the drug supply chain, including pharmaceutical manufacturers, pharmacy benefit managers, pharmacies, pharmacists and distributors, reported by Becker's Hospital Review in the last month:

Following rival drugstore chains that are offering additional health services, Rite Aid has launched a telehealth platform that connects patients to clinicians at its in-store health clinics. 

Elijah Cummings, D-Md., House Oversight and Reform Committee Chairman, plans to invite drug company executives to testify in front of the committee after the August recess, according to The Hill. 

Some of the top university hospitals in Switzerland are teaming up to offer cancer treatments to patients at one-third the cost of the commercialized process offered by Big Pharma, according to Bloomberg.